Aptus Pharma IPO Listing Preview: What to Expect Now?

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Fri Sep 26 2025

Aptus Pharma IPO Listing Preview: What to Expect Now?

Click to check Aptus Pharma IPO GMP Live.

The Aptus Pharma IPO listing is scheduled for 30th September 2025. The IPO was open for bidding from 23rd September 2025 to 25th September 2025. It is a bookbuilding IPO of ₹13.02 crores, comprising a fresh issue of 0.19 crore shares. The issue will be listed on the BSE and SME on its tentative listing date, 30th September. Scroll down to learn more about Aptus Pharma’ IPO listing expectations.

Table of Contents

Aptus Pharma IPO Listing Preview

According to recent updates, the IPO listing of Aptus Pharma is expected to be around ₹74 per share on 30th September 2025. This conclusion is based on the Current IPO GMP (grey market premium) of Aptus Pharma. However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to receive live updates on current IPO listings or GMP trends. Scroll to explore the GMP of the Aptus Pharma IPO.

Aptus Pharma IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to receive live updates on the Aptus Pharma IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
26-09-2025	₹72.00	₹4.00	₹74.00	5.71%
25-09-2025	₹72.00	₹4.00	₹74.00	5.71%
24-09-2025	₹72.00	₹8.00	₹78.00	11.43%
23-09-2025	₹72.00	₹7.00	₹77.00	10.00%
22-09-2025	₹72.00	₹7.00	₹77.00	10.00%
21-09-2025	₹72.00	₹7.00	₹77.00	10.00%
20-09-2025	₹72.00	₹7.00	₹77.00	10.00%
19-09-2025	₹72.00	₹7.00	₹77.00	10.00%
18-09-2025	₹72.00	₹0.00	₹72.00	0.00%

As of 26th September 2025, the Aptus Pharma IPO GMP stands at ₹4 per share. This means the share will likely list at ₹74 on its tentative Listing date, 30th September 2025.GMP data is subject to change based on market conditions. Please verify the live GMP status before applying for the Aptus Pharma IPO GMP. Stay informed with Univest to know about real-time information on IPOs and their GMP trends.

Aptus Pharma Limited Financials

The company’s financial analysis is crucial before applying for the Aptus Pharma IPO. Refer to the table to learn about Aptus Pharma Limited’s financials.

Year Ended	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023 (in cr.)
Assets	21.92	10.03	6.22
Revenue	24.64	17.88	13.90
Profit After Tax	3.10	0.80	0.19
EBITDA	4.76	1.49	0.57
Net Worth	6.97	1.77	0.97
Reserve and surplus	1.97	1.47	0.67
Total Borrowing	10.36	5.31	2.21

Explanation

Aptus Pharma Limited’s revenue increased by 38% from ₹17.88 crores in March 2024 to ₹24.64 crores in March 2025. Moreover, the company’s PAT rose by 288% from ₹0.80 crores to ₹3.10 crores.

How to Check Aptus Pharma IPO Allotment Status?

You can check whether the Aptus Pharma IPO allotment has been completed in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

Visit the BSE Official Website.
Navigate to the IPO Allotment Section.
Select Equity as the issue type.
Choose the Aptus Pharma IPO.
Choose whether to proceed with the PAN number or the application number.
Submit your details to get the allotment status online.

Check On the Registrar Portal

Visit the registrar portal.
Click on the allotment option.
Fill in the required details.
Click on the submit button to know your Aptus Pharma IPO allotment status.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!